who owns the patent for retatrutide FDA warns against unapproved drugs like | Michael Albert MD posted on topic How to Survive the GLP-1
Description
Following the warning, Hallandale ceased sterile compounding at their old location and moved to a new facility in Fort Lauderdale, where they resumed operations
A potential limitation of oral semaglutide is the need to dose patients in a fasted state upon waking and 30 min before consuming food, drink, or other oral medications
The most frequently reported issues for new patients were nausea, constipation, and GI issues
Lean Alkhatib: contributed to design, interpretation, drafted and critically revised the manuscript and gave final approval
